These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19935363)

  • 1. LC-MS/MS extends the range of drug analysis in pain patients.
    Mikel C; Almazan P; West R; Crews B; Latyshev S; Pesce A; West C
    Ther Drug Monit; 2009 Dec; 31(6):746-8. PubMed ID: 19935363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of illicit drug cutoff values in a pain patient population.
    West R; Pesce AJ; Crews B; Mikel C; Rosenthal M; Almazan P; Latyshev S; West C
    Clin Chim Acta; 2011 Aug; 412(17-18):1589-93. PubMed ID: 21600890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Acetylmorphine detected in the absence of morphine in pain management patients.
    Crews B; Mikel C; Latyshev S; West R; West C; Pesce A; Friel P
    Ther Drug Monit; 2009 Dec; 31(6):749-52. PubMed ID: 19745789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification.
    Maralikova B; Weinmann W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):21-30. PubMed ID: 15458717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
    Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells.
    Elens L; Veriter S; Yombi JC; Di Fazio V; Vanbinst R; Lison D; Wallemacq P; Vandercam B; Haufroid V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1805-14. PubMed ID: 19487167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method.
    McCann SJ; Gillingwater S; Keevil BG; Cooper DP; Morris MR
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):161-5. PubMed ID: 12662404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary free cortisol using liquid chromatography-tandem mass spectrometry: comparison with the urine adapted ACS:180 serum cortisol chemiluminescent immunoassay and development of a new reference range.
    McCann SJ; Gillingwater S; Keevil BG
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):112-8. PubMed ID: 15829119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous observations of codeine in patients on morphine.
    West R; Crews B; Mikel C; Almazan P; Latyshev S; Pesce A; West C
    Ther Drug Monit; 2009 Dec; 31(6):776-8. PubMed ID: 19935365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study.
    Chen Y; Miao H; Lin M; Fan G; Hong Z; Wu H; Wu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):268-77. PubMed ID: 16899417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of dextromethorphan, dextrorphan, and guaifenesin in human plasma using semi-automated liquid/liquid extraction and gradient liquid chromatography tandem mass spectrometry.
    Eichhold TH; McCauley-Myers DL; Khambe DA; Thompson GA; Hoke SH
    J Pharm Biomed Anal; 2007 Jan; 43(2):586-600. PubMed ID: 16930908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology.
    Kuepper U; Musshoff F; Madea B
    Rapid Commun Mass Spectrom; 2008 Jun; 22(12):1965-70. PubMed ID: 18491286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.